Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1995-05-03
1997-02-11
Rollins, John W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
514885, A61K 3578
Patent
active
056018290
ABSTRACT:
A pharmaceutical composition with beneficial effects in disorders which deal with cognitive, neurodegenerative and/or neuroimmune dysfunctions, especially the Alzheimer disease, characterized in that it comprises, as active ingredient, an isolated, natural hydrosoluble extract of the rhizome or leaves of Phlebodium decumanum, Polypodium aureum, Polypodium leucotomos, Polypodium vulgare, Polypodium trisereiale, Pteridium aquilinum, Dryopteris crassirhizoma and Cyathea taiwamiana, and the liposoluble fraction derivates of said extract, together with an acceptable pharmaceutical vehicle.
Diaz Alperi Joaquin
Quintanilla Almagro Eliseo
Especialidades Farmaceuticas Centrum, S.A.
Rollins John W.
LandOfFree
Pharmaceutical composition of activity in the treatment of cogni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition of activity in the treatment of cogni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition of activity in the treatment of cogni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-339813